Followers | 751 |
Posts | 16573 |
Boards Moderated | 1 |
Alias Born | 05/30/2007 |
Thursday, December 28, 2023 7:58:55 PM
+0.012 (+6.38%)
Volume: 902,141
Day Range: 0.185 - 0.21
Last Trade Time: 7:33:59 PM EST
Finviz's Oblong Inc. Target Price: $15(!) >>> https://finviz.com/quote.ashx?t=OBLG&ty=c&ta=1&p=w
$$$OBLG$$$
Recent OBLG News
- Oblong Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule • Business Wire • 03/20/2024 08:10:00 PM
- Oblong Announces Financial Results for Fourth Quarter 2023 and Provides Business Update • Business Wire • 03/19/2024 08:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 02:05:55 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/17/2024 05:15:26 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/12/2024 09:47:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/11/2024 09:00:52 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/29/2023 09:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:02:41 PM
- Oblong Announces Financial Results for Third Quarter 2023 and Provides Business Update • Business Wire • 11/14/2023 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/08/2023 09:04:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/30/2023 08:04:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2023 08:03:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/19/2023 08:35:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:01:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:39:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:18:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:03:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:09:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:05:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/28/2023 06:05:18 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 07/05/2023 08:29:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 08:22:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 08:08:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM